Based on this, any agents that can increase insulin sensitivity, such as thiazolidinediones (TZDs) and glucagon-like peptide 1 receptor agonist (GLP-1RA), are highly attractive and used as one of the first-line pharmacological treatments for infertile PCOS women. The gene discussed is INS; the disease is Infertility.